BDBM50228761 (S)-2-(2-(3-chlorophenyl)-2-oxoacetamido)-N-((S)-5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-yl)-3-methylbutanamide::(S)-2-[2-(3-chloro-phenyl)-2-oxo-acetylamino]-N-[(S)-4-guanidino-1-(thiazole-2-carbonyl)-butyl]-3-methyl-butyramide::2-[2-(3-CHLORO-PHENYL)-2-HYDROXY-ACETYLAMINO]-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-3-METHYL-BUTYRAMIDE::CHEMBL429733
SMILES [#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6](=O)-c1cccc(Cl)c1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-c1nccs1
InChI Key InChIKey=NZMZDRVEUJTADA-HOTGVXAUSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 50228761
TargetCoagulation factor XI(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human factor 11aMore data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL